pages:
-
A Randomized, Double-Blind Study to Evaluate the Impact of AXS-05 on Smoking Behavior.
-
A randomized, double-blind, dose-ranging, placebo-controlled, Phase 2a
evaluation of the safety, tolerability, and pharmacokinetics of PLN-74809
in participants with primary sclerosing cholangitis (PSC) and suspected
liver fibrosis (INTEGRIS-PSC)
-
A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD)
-
A Randomized, Double-Blind, MultiNational Study to Prevent Major Vascular Events with Ticagrelor Compared to Aspirin (ASA) in Patients with Acute Ischaemic Stroke or TIA (SOCRATES)
-
A Randomized, Double-blind, Placebo Controlled Efficacy, Safety, and Tolerability Study of up to 20 mL of DFA-02 in Patients Undergoing Abdominal Surgery
-
A Randomized, Double-Blind, Placebo Controlled Multiple Ascending Dose
Study to Evaluate the Safety, Tolerability, Pharmacokinetics,
Pharmacodynamics and Immunogenicity of ABBV-0805 in Patients with
Parkinson's Disease
-
A Randomized, Double-Blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects with Generalized Refractory Myasthenia Gravis (GMG)
-
A Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Ambulatory and Non-Ambulatory Participants with Spinal Muscular Atrophy with Open-Lab
-
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of a Single Infusion of Bezlotoxumab (MK-6072, Human Monoclonal Antibody to C. difficile Toxin B) in Children Aged 1 to
-
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
Comparing CB-839 in Combination with Cabozantinib (CB-Cabo) vs.
Placebo with Cabozantinib (Pbo-Cabo) in Patients with Advanced or
Metastatic Renal Cell Carcinoma (RCC)
-
A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, PCI-32765 (Ibrutinib), in Combination with Bendamustine and Rituximab (BR) in Subjects With Newly Diagnosed Mantle Cell Lymphoma
-
A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Traumatic Cervical Spinal Cord Injury
-
A Randomized, Double-Blind, Placebo-Controlled Study comparing CroFab versus Placebo with Rescue Treatment for Copperhead Snake Envenomation
-
A Randomized, Double-Blind, Placebo-controlled Study of SD-809 (Dutetrabenazine) for the Treatement of Moderate to Severe Tardive Dyskinesia
-
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Single Dose of Exebacase in Adult Patients Receiving Standard of Care Antibiotics for the Treatment of Staphylococcus aureus
Bloodstream Infections (Bacteremia),
-
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Amatuximab in Combination with Pemetrexed and Cisplatin in Subjects with Unresectable Malignant Pleural Mesothelioma
-
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, PK, and PD Effects of REGN2477-1033 in Obese Patients with Type 2 Diabetes Mellitus
-
A Randomized, Double-Blind, Placebo-Controlled Study To Investigate The Efficacy And Safety Of Carisbamate (Ykp509) As Adjunctive Treatment For Seizures Associated With Lennox-Gastaut Syndrome In Children And Adults, With Optional Open-Label Extensio
-
A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer (Ferric Carboxymaltose) as Treatment for Heart Failure with Iron Deficiency.
-
A Randomized, double-blind, placebo-controlled trial of urate elevating inosine treatment to show clinical decline in early Parkinson Disease
-
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE FINDING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PADSEVONIL AS ADJUNCTIVE TREATMENT OF
FOCAL-ONSET SEIZURES IN ADULT SUBJECTS WITH DRUG-RESISTANT EPILEPSY
-
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study of Buntanetap in Participants with Mild to Moderate Alzheimer's Disease
-
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naive Adult Patients with Generalized Myasthenia Gravis
-
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial to Evaluate the Safety and Efficacy of Eculizumab in Patients with Relapsing Neuromyelitis Optica
-
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE SOLID DISPERSION (SSD) TABLETS FOR THE DELAY OF ENCEPHALOPATHY DECOMPENSATION IN CIRRHOSIS (RED-C)
-
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Zilebesiran Used as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication
-
A randomized, double-blind, placebo-controlled, multicenter, phase 3 efficacy and safety study of 2 dose levels of subcutaneious anakinra in patients with Still's disease
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Trial of Crenolanib in Subjects with Advanced or Metastatic Gastrointestinal Stromal Tumors with a D842V Mutation in the PDGFRA Gene
Research Grant
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Seamless, Adaptive, Safety, Dose-Finding, and Phase 3 Clinical Study of UX701 AAV-Mediated Gene Transfer for the Treatment of Wilson Disease
-
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of BIO89-100
Research Grant
pages: